Waterdrop (WDH) Q4 2025 earnings review
Staggering Revenue Growth Masking Severe Margin Compression
Waterdrop delivered an eye-popping 105.5% YoY revenue growth in Q4, driven entirely by a sudden explosion in 'Technical Service Income,' which skyrocketed from RMB 1.8M to RMB 639.6M. However, the quality of this top-line surge is highly questionable. To achieve this growth, Sales & Marketing expenses were ramped up by 178.4% YoY. As a result, while absolute operating profit grew, operating profit margins collapsed sequentially from 11.7% in Q3 to just 5.9% in Q4. Management attributes the success to heavy AI integration, but the financials suggest the company is buying top-line growth at the expense of unit economics.
🐂 Bull Case
The 125% YoY growth in the insurance segment proves Waterdrop can successfully monetize its B2B technical capabilities. Technical service income reached RMB 639.6M, representing a massive new revenue pillar outside traditional brokerage.
Management's AI bet is showing tangible output. Premiums facilitated by the 'AI Medical Insurance Expert' grew 145% QoQ, and AI agents are independently handling over 1.4 million inquiries monthly, proving the technology can scale.
🐻 Bear Case
Despite revenue more than doubling, operating margins fell to 5.9% (from 11.7% in Q3). S&M costs surged 178% and referral fees jumped RMB 283.9M, indicating the new 'technical services' revenue might be low-margin traffic arbitrage.
The legacy Crowdfunding segment—the top of Waterdrop's user acquisition funnel—declined 5.7% YoY in revenue and widened its operating loss to RMB 35.3M. If the top of the funnel decays, the downstream insurance cross-selling will suffer.
⚖️ Verdict: ⚪
Neutral. The sheer scale of top-line acceleration is impressive and validates management's FY25 growth promises. However, buying revenue through hyper-inflated marketing spend and referral fees destroys operating leverage. Until the margin profile stabilizes, this remains a 'show me' story.
Key Themes
The Technical Services Boom
Accelerating. Insurance-related income hit RMB 1.31B (+125% YoY). Stripping away the core brokerage business, the true catalyst was Technical Service Income, which shot from virtually zero (RMB 1.8M a year ago) to RMB 639.6M. This segment provides analytics, risk assessment, and user referrals to third-party insurers. This fundamentally shifts Waterdrop's profile from a pure broker to a B2B technology vendor.
Customer Acquisition Costs Spiraling Out of Control
Reversing. After quarters of disciplined cost control and margin expansion, Waterdrop reversed course. Q4 Sales and Marketing expenses ballooned by 178.4% YoY to RMB 506.8M, primarily due to third-party traffic channel costs. Simultaneously, Operating Costs jumped 109% driven by a RMB 283.9M increase in referral fees. This indicates the company is paying aggressively for traffic to fuel its new technical service revenue, sacrificing margins.
Digital Clinical Trials Reaching Scale
Accelerating. The E-Find Platform continues to be a quiet but consistent growth engine. Digital clinical trial solution income grew 39.9% YoY to RMB 35.7M. The company has now cumulatively enrolled 14,555 patients across 1,611 clinical trial programs, partnering with 224 pharma and CROs (up from 198 in Q2).
Crowdfunding Stagnation Continues
Stable. The medical crowdfunding platform saw service fees decline by 5.7% YoY to RMB 61.4M. More concerningly, the segment's operating loss widened to RMB 35.3M (from RMB 22.0M a year ago). While the platform remains a vital social good and top-of-funnel acquisition tool (72.3 billion RMB cumulatively donated), its standalone financials are deteriorating.
Other KPIs
Accelerating absolute profit. Up 58.9% YoY compared to RMB 107.1M in 24Q4. The exclusion of share-based compensation (RMB 8.2M) creates a clean view of profitability. However, the profit growth significantly lagged the 105.5% revenue growth, highlighting the margin compression.
Stable. Decrease from RMB 3.67B at the end of FY24 is largely attributable to active capital returns (dividends and over $118M in cumulative share repurchases). The balance sheet remains highly liquid with minimal short-term debt (RMB 47.0M), providing ample firepower for further AI investments.
Accelerating. Up 21.9% YoY. While management highlights massive AI deployments, R&D spend remains a relatively small fraction of total revenue (4.7%) compared to the mammoth 35.9% spent on Sales and Marketing. This suggests Waterdrop is utilizing application-layer AI rather than building capital-intensive foundational models.
Guidance
Accelerating. In 25Q1, management guided for 'over 20% annual revenue growth for 2025' but warned that increased H2 investments might impact margins. They massively over-delivered on the top line (+43.5%) while the exact margin warning materialized in Q4.
Stable. The Board approved a cash dividend of US$0.03 per ADS. This represents a continuous commitment to returning capital to shareholders, consistent with the US$10.9 million dividend paid out in Q2 2025.
Key Questions
Nature of Technical Service Income
Technical Service Income skyrocketed to RMB 639.6M. What is the specific breakdown of this revenue (analytics vs. user referrals), and what is the standalone gross margin of this business line considering the simultaneous spike in referral and marketing costs?
Margin Floor Expectations
Operating margin dropped sequentially from 11.7% to 5.9%. Was Q4 a one-time aggressive marketing push, or is this 5-6% margin the new normal structural floor for the business as it pivots toward B2B technical services?
Crowdfunding Path to Breakeven
The Crowdfunding segment operating losses have widened to RMB 35.3M this quarter. What is the strategic timeline to bring this segment back to breakeven, or is management comfortable running it as a permanent loss-leader for top-of-funnel acquisition?